The present disclosure provides an electrolyte and an electrochemical energy storage device, the electrolyte comprises an electrolyte salt and an additive. The additive comprises a sulfonic ester cyclic quaternary ammonium salt and a multinitrile compound. The sulfonic ester cyclic quaternary ammonium salt and the multinitrile compound can form a dense and uniform passive film with high ionic conductivity on a surface of each of the positive electrode film and the negative electrode film, so as to prevent continuous oxidation and reduction reaction from occurring between the electrolyte and the positive electrode film and the negative electrode film and make the electrochemical energy storage device has excellent high temperature cycle performance and high temperature storage performance.

The present disclosure provides an electrolyte and an electrochemical energy storage device, the electrolyte comprises an electrolyte salt and an additive. The additive comprises a sulfonic ester cyclic quaternary ammonium salt and a multinitrile compound. The sulfonic ester cyclic quaternary ammonium salt and the multinitrile compound can form a dense and uniform passive film with high ionic conductivity on a surface of each of the positive electrode film and the negative electrode film, so as to prevent continuous oxidation and reduction reaction from occurring between the electrolyte and the positive electrode film and the negative electrode film and make the electrochemical energy storage device has excellent high temperature cycle performance and high temperature storage performance.

The present invention relates to a novel compound and a pharmaceutical composition comprising the same as an active ingredient. The novel compound, which is obtained by means of carrying out chemical modification in a mother structure showing excellent AMP-activated protein kinase (AMPK) activation efficacy and in silico binding capacity, enables effective prevention or treatment of degenerative neurological disorders by means of effectively inducing AMP-activated protein kinase enzyme activation.

The present invention relates to novel sulfur derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of chemokine receptors.

The present invention relates to novel sulfur derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of chemokine receptors.

The invention relates to a process for the production of amide bonds, in particular peptide bonds, with the aid of novel amide linking reagents containing an anion of the formula (I), to the novel reagents, and to the preparation thereof.

A method for producing an amine oxide by oxidation of a tertiary amine in a reactor under continuous introduction of tertiary amine in a reaction fluid and export of amine oxide, wherein a suitable surface-to-volume ratio and/or a suitable flow speed with corresponding surface/volume loads are selected in the continuous process. The reaction fluid is usually reacted in the reactor with a laminar flow.

A method for producing an amine oxide by oxidation of a tertiary amine in a reactor under continuous introduction of tertiary amine in a reaction fluid and export of amine oxide, wherein a suitable surface-to-volume ratio and/or a suitable flow speed with corresponding surface/volume loads are selected in the continuous process. The reaction fluid is usually reacted in the reactor with a laminar flow.

The invention relates to a process for the production of amide bonds, in particular peptide bonds, with the aid of novel amide linking reagents containing an anion of the formula (I), to the novel reagents, and to the preparation thereof.

A method of forming a dental composite includes photopolymerizing a dental composition. The dental composition includes a free-radically polymerizable (meth)acrylate resin, 75 percent by weight or greater of filler particles, and about 0.005 percent to about 5 percent by weight of at least one polymerizable stable radical. The photopolymerizing forms the dental composite such that the dental composite has a flexural modulus of about 9500 MPa or greater and the polymerizable stable radical reduces shrinkage stress of the dental composite caused by the photopolymerizing by 10% or greater. A method of forming a dental composite composition includes combining a free-radically polymerizable (meth)acrylate resin, 75 percent by weight or greater of filler particles, and about 0.005 percent to about 5 percent by weight of at least one polymerizable stable radical to form the dental composite composition.